Sumatriptan And Naproxen Sodium Tablet, Film Coated
Product Images NDC 16714-891

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan And Naproxen Sodium (NDC 16714-891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sumatriptan-and-naproxen-figure1 (Spl Sumatriptan And Naproxen Figure1)

The text describes a graph (Figure 1) that shows the percentage of adult patients who experience relief from initial headache pain within 2 hours of taking Sumatriptan and Naproxen Sodium Tablets 85 mg/ 500 mg, Sumatriptan 85 mg and Naproxen Sodium 500 mg, or a placebo. The graph shows that the combination of Sumatriptan and Naproxen Sodium provided the highest percentage (100%) of headache pain relief within the timeframe. The graph is marked with time points up to 2 hours post-dose.*

FDA Label Image

Spl-sumatriptan-and-naproxen-figure2 (Spl Sumatriptan And Naproxen Figure2)

The text describes a figure showing the probability of adults taking a rescue medication over 24 hours following the first dose. It shows the probability for four different medications: placebo, naproxen, sumatriptan, and sumatriptan and naproxen sodium tablets. The X-axis represents the time in hours postdose, ranging from 6 to 14, and the Y-axis represents the percentage of patients taking a rescue medication.*

FDA Label Image

Spl-sumatriptan-and-naproxen-label (Spl Sumatriptan And Naproxen Label)

This is a pack of Sumatriptan and Naproxen Sodium Tablets with NDC 16714-891-01. The medication guide is provided separately to each patient, and the pack contains 9 tablets. The copyright belongs to NorthStar Healthcare Holdings UC, and the labeling is available upon opening.*

FDA Label Image

Spl-sumatriptan-and-naproxen-naproxen-sodium-str (Spl Sumatriptan And Naproxen Naproxen Sodium Str)

FDA Label Image

Spl-sumatriptan-and-naproxen-sumatriptan-str (Spl Sumatriptan And Naproxen Sumatriptan Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.